Skip to main content
Transpact Enterprises Limited logo

Transpact Enterprises Limited — Investor Relations & Filings

Ticker · 542765 ISIN · INE06YD01010 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-30 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 542765

About Transpact Enterprises Limited

https://transpact.in/

Transpact Enterprises Limited focuses on the design, development, and commercialization of specialized rehabilitation and assistive technology devices. The company primarily develops therapeutic solutions for individuals with neuro-developmental conditions such as cerebral palsy, autism, and sensory processing disorders. Its core product offering includes the Vestibulator, an automated therapeutic system designed to provide vestibular stimulation and sensory integration. By integrating mechanical engineering with therapeutic protocols, the company provides tools for clinical and home-based rehabilitation. Its activities center on research-driven product innovation aimed at improving functional independence and quality of life for patients requiring long-term neuro-rehabilitation support.

Recent filings

Filing Released Lang Actions
Transpact Enterprises Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Interim / Quarterly Report Classification · 76% confidence The document is an official board meeting outcome submitted to the stock exchange under SEBI Listing Regulation 33, containing the audited standalone financial results for the half-year and year ended March 31, 2026, with detailed financial statements (statement of assets and liabilities, cash flows) and the independent auditor’s report. It is not a full annual report (10-K) or mere announcement of availability; instead it provides substantive financial data for a period shorter than a full fiscal year (half-year) and thus matches the criteria for an Interim/Quarterly Report rather than a simple report publication notice or fallback regulatory filing. FY 2026
2026-05-30 English
Transpact Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial Statements ....
Regulatory Filings Classification · 99% confidence The document is a stock exchange filing under SEBI LODR Regulation 29(2) notifying the date of a Board of Directors meeting to consider and adopt audited financial statements. It contains no actual financial data or results, nor any change in management. It is neither an Annual/Interim Report nor an earnings release, but a routine regulatory announcement. This fits the fallback category “Regulatory Filings (RNS)”.
2026-05-23 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.